Editorial: role of leucine-metformin-sildenafil combination in the treatment of nonalcoholic fatty liver disease (NAFLD)
Aliment Pharmacol Ther
.
2018 Aug;48(3):378-379.
doi: 10.1111/apt.14819.
Authors
M Noureddin
1
,
R Loomba
2
Affiliations
1
Division of Digestive and Liver Diseases, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
2
Division of Gastroenterology, NAFLD Research Center, University of California at San Diego, San Diego, CA, USA.
PMID:
29998503
DOI:
10.1111/apt.14819
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Hypoglycemic Agents
Leucine
Metformin*
Non-alcoholic Fatty Liver Disease*
Sildenafil Citrate
Substances
Hypoglycemic Agents
Metformin
Sildenafil Citrate
Leucine